PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients

Genes and Immunity

Volumn 11, Issue 8, 2010, Pages 665-670

  Chiarini, M ^a   Sabelli, C ^a   Melotti, P ^b   Garlanda, C ^c   Savoldi, G ^a   Mazza, C ^a   Padoan, R ^a   Plebani, A ^a   Mantovani, A ^c,d   Notarangelo, L D ^a   Assael, B M ^b   Badolato, R ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Cystic Fibrosis Center   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

cystic fibrosis; gene polymorphism; innate immunity; modifier genes; pentraxin 3; Pseudomonas aeruginosa

Indexed keywords

PENTRAXIN 3;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CAUCASIAN; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SINGLE NUCLEOTIDE POLYMORPHISM;

C-REACTIVE PROTEIN; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; IMMUNITY, INNATE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SERUM AMYLOID P-COMPONENT;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 78649712098     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.41     Document Type: Article

References (22)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080. (Pubitemid 19231815)
2. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H et al. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). N Engl J Med 1990; 323: 1517-1522.
3. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50: 1178-1184.
4. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
5. Diniz SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, MantoVani A et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 2004; 75: 649-656.
6. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentax-ins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.
7. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19: 203-214.
8. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
9. Garlanda C, Bottazzi B, Bastone A, MantoVani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23: 337-366.
10. Doni A, Peri G, Chieppa M, Allavena P, Pasqualini F, Vago L et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol 2003; 33: 2886-2893.
11. Nauta AJ, De Haij S, Bottazzi B, MantoVani A, Borrias MC, Aten J et al. Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int 2005; 67: 543-553.
12. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420: 182-186.
13. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, Aaby P et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 2007; 8: 456-467.
14. Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, Moalli F et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804.
15. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420: 182-186.
16. Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005; 22: 551-560.
17. Tesse R, Cardinale F, Santostasi T, Polizzi A, Manca A, Mappa L et al. Association of beta-defensin-1 gene polymorphisms with Pseudomonas aeruginosa airway colonization in cystic fibrosis. Genes Immun 2008; 9: 57-60.
18. Corvol H, Boelle PY, Brouard J, Knauer N, Chadelat K, Henrion-Caude A et al. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr Pulmonol 2008; 43: 1224-1232.
19. Brazova J, Sismova K, Vavrova V, Bartosova J, Macek Jr M, Lauschman H et al. Polymorphisms of TGF-beta 1 in cystic fibrosis patients. Clin Immunol 2006; 121: 350-357.
20. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Hoiby N et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431-437.
21. McDougal KE, Green DM, Vanscoy LL, Fallin MD, Grow M, Cheng S et al. Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. Eur J Hum Genet 2010; 18: 680-684.
22. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23: 545-549.